Online citations, reference lists, and bibliographies.
← Back to Search

Coumarin Derivatives As Potential Antitumor Agents: Growth Inhibition, Apoptosis Induction And Multidrug Resistance Reverting Activity.

A. Bisi, C. Cappadone, A. Rampa, G. Farruggia, A. Sargenti, F. Belluti, R. D. Di Martino, E. Malucelli, A. Meluzzi, S. Iotti, S. Gobbi
Published 2017 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A small library of coumarins, carrying butynyl-amino chains, was synthesized continuing our studies in the field of MDR reverting ageEnts and in order to obtain multipotent agents to combat malignancies. In particular, the reported anticancer and chemopreventive natural product 7-isopentenyloxycoumarin was linked to different terminal amines, selected on the basis of our previously reported results. The anticancer behaviour and the MDR reverting ability of the new compounds were evaluated on human colon cancer cells, particularly prone to develop the MDR phenotype. Some of the new derivatives showed promising effects, directly acting as cytotoxic compounds and/or counteracting MDR phenomenon. Compound 1e emerged as the most interesting of this series, showing a multipotent biological profile and suggesting that conjugation of an appropriate coumarin core with a properly selected butynyl-amino chain allows to obtain novel hybrid molecules endowed with improved in vitro antitumor activity.
This paper references
10.1038/bjc.1986.206
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.
M. Grandi (1986)
Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
A. Dantzig (1996)
10.1016/S0925-4439(97)00026-4
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.
T. Litman (1997)
10.1152/PHYSREV.1997.77.2.545
Kinetics of the multidrug transporter (P-glycoprotein) and its reversal.
W. Stein (1997)
Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
M. Fanciulli (2000)
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
P. Mistry (2001)
10.1016/S0163-7258(02)00298-X
The biochemistry and medical significance of the flavonoids.
B. Havsteen (2002)
10.1248/BPB.25.244
Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion.
M. Baba (2002)
10.1007/BF00685907
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance
B. Hill (2004)
10.1016/j.clpt.2005.05.011
Transporters and drug therapy: Implications for drug disposition and disease
R. Ho (2005)
10.1007/BF01377115
The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines
R. B. Myers (2005)
10.1021/JM070235M
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
A. Andreani (2007)
10.1016/j.bmc.2008.05.040
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
A. Bisi (2008)
10.1177/1934578X0900401228
Insights on Novel Biologically Active Natural Products: 7-Isopentenyloxycoumarin
F. Epifano (2009)
10.2174/156802609787521553
ABC pumps and their role in active drug transport.
N. Colabufo (2009)
10.1016/j.cbi.2009.06.015
Cytotoxicity of methoctramine and methoctramine-related polyamines.
M. Zini (2009)
10.1038/nrd3028
Membrane transporters in drug development
K. Giacomini (2010)
10.1016/j.tox.2010.03.012
Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.
Regine Lüpertz (2010)
10.2174/092986710790936284
Coumarins: old compounds with novel promising therapeutic perspectives.
M. Riveiro (2010)
10.1016/j.bmcl.2011.05.089
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
C. Bruyère (2011)
10.2174/092986712800167392
Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
A. Palmeira (2012)
10.1021/np3003468
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
O. Wesołowska (2012)
10.1016/j.drup.2012.03.002
Collateral sensitivity as a strategy against cancer multidrug resistance.
Kristen M Pluchino (2012)
10.1002/cmdc.201300291
Sigma‐2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity
M. Niso (2013)
10.2174/1381612811319210013
Current developments of coumarin compounds in medicinal chemistry.
Xin-Mei Peng (2013)
10.1186/2008-2231-22-3
The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage
F. Haghighi (2013)
10.1016/j.ejphar.2013.11.002
Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.
K. Lee (2014)
10.3389/fonc.2014.00002
Small and Innovative Molecules as New Strategy to Revert MDR
Laura Zinzi (2014)
10.1016/j.bmc.2014.05.032
Coumarin hybrids as novel therapeutic agents.
Sonali Sandhu (2014)
10.1016/j.ejmech.2015.01.004
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold.
A. Bisi (2015)
10.1038/srep16538
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
S. Castiglioni (2015)
10.1016/j.ejmech.2014.10.076
Mannich bases in medicinal chemistry and drug design
G. Roman (2015)
10.3109/14756366.2016.1149476
Advances in plant-based inhibitors of P-glycoprotein
Jun Yu (2016)



This paper is referenced by
10.1016/j.microc.2020.105797
Optical properties of solute molecules: Environmental effects, challenges, and their practical implications
M. Homocianu (2021)
10.1039/d1bm00424g
Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer.
Avijit Ghosh (2021)
10.3390/molecules25235685
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
Saad Alghamdi (2020)
10.1007/978-981-15-5999-0
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
Manish Kumar (2020)
10.3390/molecules25245923
7-Isopentenyloxycoumarin: What Is New across the Last Decade
Francesca Preziuso (2020)
10.1002/aoc.5948
Ce(IV) immobilized on halloysite nanotube–functionalized dendrimer (Ce(IV)–G2): A novel and efficient dendritic catalyst for the synthesis of pyrido[3,2‐ c ]coumarin derivatives
Tahereh Ataee-Kachouei (2020)
10.1080/17518253.2020.1762935
Synthesis and antioxidant properties of some new thiazolyl coumarin derivatives
D. Bensalah (2020)
10.1007/978-981-15-5999-0_4
Natural Products as Chemosensitizers for Adjunct Therapy in Cancer Management
Suchisnigdha Datta (2020)
10.1016/j.bioorg.2020.104163
Recent advancements of coumarin-based anticancer agents: An up-to-date review.
T. Al-Warhi (2020)
Cytotoxic Effects of Hydroxy Coumarin Derivatives on Mouse Neuroblastoma N2a Cell Line
J. Sargolzaei (2020)
10.1016/j.molliq.2020.113509
Experimental and DFT/TD-DFT computational investigations of the solvent effect on the spectral properties of nitro substituted pyridino[3,4-c]coumarins
M. Shkoor (2020)
10.1002/iub.2215
Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
M. Majidinia (2020)
10.1002/ardp.202000137
New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations
Yasemin Budama-Kilinc (2020)
10.21873/anticanres.13818
Bis(4-hydroxy-2H-chromen-2-one) Coumarin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Aromatase Inhibition
L. H. Ramdani (2019)
10.1016/j.jorganchem.2019.120968
Synthesis, characterization and antitumor activity of novel ferrocene-coumarin conjugates
Jing-Na Wei (2019)
10.1016/j.ejmech.2019.01.070
Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
H. Dai (2019)
10.1002/SLCT.201803707
Facile and Green One‐Pot Synthesis of Fluorophore Chromeno[4,3‐b]quinolin‐6‐one Derivatives Catalyzed by Halloysite Nanoclay under Solvent‐free Conditions
Tahereh Ataee-Kachouei (2019)
10.3389/fphar.2019.00400
Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
J. Sachs (2019)
10.1016/j.bioorg.2019.103530
Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
Yu Wang (2019)
10.1016/J.TALANTA.2019.04.038
Concentration and distribution of silica nanoparticles in colon cancer cells assessed by synchrotron based X-ray techniques.
Alessandra Procopio (2019)
10.1080/00397911.2019.1657150
Click synthesis of N1-(β-D-ribofuranosyl)-C4-(coumarin-4″-yl)-1,2,3-triazoles
Vipin K. Maikhuri (2019)
10.3390/ijms21010126
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
T. Khomenko (2019)
10.2174/1573406415666190416121448
Hybrids of Coumarin Derivatives as potent and multifunctional bioactive agents: A review.
Ioannis Fotopoulos (2019)
10.1039/C8NJ02388C
Oxa/thiazole-tetrahydropyran triazole-linked hybrids with selective antiproliferative activity against human tumour cells
Guillermo Valdomir (2018)
10.1186/s12935-018-0548-5
A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
Jia Hua-feng (2018)
10.1016/j.fitote.2018.09.009
Phytochemical and antimicrobial study of Pilocarpus pennatifolius Lemaire.
Gabriele do Carmo (2018)
10.1080/00397911.2018.1430237
Catalyst-free three-component approach to efficient synthesis of chromeno[4,3-b]pyrrol-4(1H)-one derivatives
X. Yang (2018)
10.1002/JHET.3115
Synthesis, Characterization, and Cytotoxicity Evaluation of Some New Benzo[f]coumarin Derivatives
K. Mohamed (2018)
10.1177/1559325818796014
7-Isopenthenyloxycoumarin, Arctigenin, and Hesperidin Modify Myeloid Cell Leukemia Type-1 (Mcl-1) Gene Expression by Hormesis in K562 Cell Line
Zahra Kafi (2018)
10.1080/1061186X.2017.1379525
Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin
Li Qin (2018)
10.3390/pharmaceutics10030127
The Effects of Synthetically Modified Natural Compounds on ABC Transporters
Daniel D. E. Dantzic (2018)
10.1016/j.bmcl.2017.08.044
Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
N. Lv (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar